Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-001499-55-FI
EUCTR2008-001499-55-FI
Active, not recruiting
Not Applicable

Treatment Monitoring of Advanced Colorectal cancer with 18F-FDG PET/CT

Turku PET Centre0 sites140 target enrollmentMarch 19, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsCampto/IrinotecanAvastinOxaliplatin/EloxatinFlurablastinerbituxxeloda

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Turku PET Centre
Enrollment
140
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Turku PET Centre

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
Completed
Not Applicable
Colomid: Midkine as a predictive marker in colorectal cancer
ACTRN12613000111774Calvary Mater Newcastle Hospital33
Not yet recruiting
Not Applicable
Refractory advanced colorectal cancer in the treatment with integrated traditional Chinese and western medicine: a multi-center clinical studycolorectal cancer
ITMCTR2200006741onghua Hospital, Shanghai University of Traditional Chinese Medicine
Terminated
Not Applicable
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CTColorectal Cancer
NCT00823810Turku University Hospital20
Recruiting
Not Applicable
Treatment of Recurrent and Advance Colorectal Cancer (TRACC): A prospective multi-site registryAdvanced Colorectal Cancer
ACTRN12618000404224Biogrid3,000